| Joyce Urban, CPNP-AC | |
|
8081 Innovation Park Dr Ste 765, Fairfax, VA 22031-4867 | |
| (571) 472-1717 | |
| Not Available |
| Full Name | Joyce Urban |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Pediatrics |
| Location | 8081 Innovation Park Dr Ste 765, Fairfax, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306627450 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0207X | Pediatrics - Pediatric Hematology-oncology | 0024188324 (Virginia) | Secondary |
| 363LP0200X | Nurse Practitioner - Pediatrics | 0024188324 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joyce Urban, CPNP-AC 11 Fairmont Pl, Sterling, VA 20165-5769 Ph: (571) 239-4404 | Joyce Urban, CPNP-AC 8081 Innovation Park Dr Ste 765, Fairfax, VA 22031-4867 Ph: (571) 472-1717 |
News Archive
Health Net, Inc. announced today that the Centers for Medicare & Medicaid Services (CMS) notified the company of its intent to impose intermediate sanctions suspending the marketing and enrollment of new members of all Health Net Medicare Advantage Prescription Drug (MAPD) and stand-alone Prescription Drug Plan (Part D) contracts, effective November 20, 2010.
Boston Scientific Corporation today announced financial results for the third quarter ended September 30, 2009, as well as guidance for net sales and earnings per share (EPS) for the fourth quarter and full year 2009.
USA Today reports on the ripple effect of this week's retirement announcements by Sen. Chris Dodd, D-Conn., and Sen. Byron Dorgan, D-N.D.: The "[t]wo Senate retirements have focused Democrats like a laser on their growing November election challenges, but a more pressing contest is less than two weeks away in an unlikely place: Massachusetts." Democrats are favored to retain the seat of the late Sen. Edward M. Kennedy, but Republicans "have increasingly touted the Jan. 19 special election as an opportunity for an upset."
AirStrip Technologies, a pioneer in mobile medical software applications, today announced that it has received U.S. Food and Drug Administration (FDA) clearance to market the AirStrip Remote Patient Monitoring solution (RPM), including AirStrip RPM CRITICAL CARE and AirStrip RPM CARDIOLOGY.
PTC Therapeutics, Inc. and Genzyme, a Sanofi company, announced today the restructuring of their collaboration. Under the original agreement, PTC held commercial rights for the U.S. and Canada and Genzyme held commercial rights in all other countries.
› Verified 7 days ago